We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMTR
6951
DELISTED
9 Meters Biopharma
NMTR
$8K ﹤0.01%
56
+10
+22% +$1.56K
MLVF
6952
DELISTED
Malvern Bancorp, Inc.
MLVF
$8K ﹤0.01%
+293
New +$7.15K
AGFS
6953
DELISTED
AgroFresh Solutions Inc
AGFS
$8K ﹤0.01%
1,202
+601
+100% +$4.51K
OPNT
6954
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
$8K ﹤0.01%
+218
New +$8.13K
HLG
6955
DELISTED
Hailiang Education Group Inc. American Depositary Shares
HLG
$8K ﹤0.01%
426
+421
+8,420% +$5.96K
GPL
6956
DELISTED
Great Panther Mining Limited
GPL
$8K ﹤0.01%
+656
New +$8.46K
SRRA
6957
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$8K ﹤0.01%
+128
New +$7.51K
ADXS
6958
DELISTED
Advaxis Inc
ADXS
$8K ﹤0.01%
122
+102
+510% +$9.41K
TWNKW
6959
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$8K ﹤0.01%
3,972
-180
-4% -$410
SLCT
6960
DELISTED
Select Bancorp, Inc.
SLCT
$8K ﹤0.01%
707
-2,017
-74% -$23.7K
SNDE
6961
DELISTED
Sundance Energy Inc. Common Stock
SNDE
$8K ﹤0.01%
173
-4
-2% -$180
AKCA
6962
DELISTED
Akcea Therapeutics Inc
AKCA
$8K ﹤0.01%
+293
New +$5.42K
MFSF
6963
DELISTED
MutualFirst Financial Inc
MFSF
$8K ﹤0.01%
+201
New +$7.06K
DERM
6964
DELISTED
Dermira, Inc.
DERM
$8K ﹤0.01%
300
-1,115
-79% -$29.2K
TPGH.U
6965
DELISTED
TPG Pace Holdings Corp. Units, each consisting of one Class A ordinary share, $.0001 par value, and
TPGH.U
$8K ﹤0.01%
+770
New +$7.93K
HIVE
6966
DELISTED
Aerohive Networks
HIVE
$8K ﹤0.01%
1,977
-1,639
-45% -$6.57K
HFBC
6967
DELISTED
HopFed Bancorp Inc
HFBC
$8K ﹤0.01%
520
-886
-63% -$12.6K
EFFE
6968
DELISTED
Global X JPMorgan Efficiente Index ETF
EFFE
$8K ﹤0.01%
324
-175
-35% -$4.56K
GNCA
6969
DELISTED
Genocea Biosciences, Inc.
GNCA
$8K ﹤0.01%
710
+437
+160% +$16.6K
ECYT
6970
DELISTED
Endocyte, Inc. Common Stock
ECYT
$8K ﹤0.01%
6,000
-380
-6% -$529
NAP
6971
DELISTED
Navios Maritime Midstream Partrs
NAP
$8K ﹤0.01%
1,028
-1,232
-55% -$10.7K
KAACU
6972
DELISTED
Kayne Anderson Acquisition Corp. Unit
KAACU
$8K ﹤0.01%
766
-1,375
-64% -$13.8K
STI.WS.B
6973
DELISTED
Suntrust Banks Inc
STI.WS.B
$8K ﹤0.01%
+500
New +$6.88K
SPUN
6974
DELISTED
VanEck Vectors Spin-Off ETF
SPUN
$8K ﹤0.01%
344
+244
+244% +$5.55K
CGI
6975
DELISTED
Celadon Group Inc
CGI
$8K ﹤0.01%
1,249
+189
+18% +$891

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.